PharmaDrug acquires Sairiyo Therapeutics in a share exchange deal
TORONTO: PharmaDrug Inc. it has completed the previously announced acquisition of Sairiyo Therapeutics Inc. on February 2, 2021. Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases…